GLENMEDE TRUST CO NA - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2020$29,000
-19.4%
3000.0%0.00%
Q2 2020$36,000
+16.1%
3000.0%0.00%
Q1 2020$31,0000.0%3000.0%0.00%
Q4 2019$31,000
-8.8%
3000.0%0.00%
Q3 2019$34,000
-33.3%
3000.0%0.00%
Q2 2019$51,000
-3.8%
300
-4.8%
0.00%
Q1 2019$53,000
+76.7%
3150.0%0.00%
Q4 2018$30,000
-31.8%
3150.0%0.00%
Q2 2018$44,000
+57.1%
315
+46.5%
0.00%
Q1 2018$28,0000.0%2150.0%0.00%
Q4 2017$28,000
+33.3%
2150.0%0.00%
Q3 2017$21,000
+2000.0%
215
+1333.3%
0.00%
Q2 2017$1,0000.0%150.0%0.00%
Q1 2017$1,0000.0%150.0%0.00%
Q4 2016$1,000150.00%
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders